Science Blog

Understanding Neurodegenerative Diseases with Wearable Sensors

Posted by Jen Blankenship on November 4, 2021

Millions of people across the globe struggle with neurodegenerative diseases every day. Neurodegenerative diseases are characterized by a breakdown of the central and peripheral nervous systems and cause progressive deterioration of a normally functioning human body. However, a significant challenge in studying neurodegenerative diseases is that direct measurements of neurological systems are invasive and expensive.

Wearable sensors can be used to understand disease progression and manifestation by measuring physical symptoms and physiological outcomes.

Read More

The Value of Exploratory Endpoints in Early Phase Trials

Posted by Kate Lyden on October 5, 2021

Drug development and clinical care models continue to take a more patient-centered approach. Putting the patient at the center of all phases of medicine is a shift initiated by the FDA. Systematic governance and policy development are currently underway.

A key component to supporting this paradigm shift is the use of real-world evidence collected with wearable sensors. Despite their enormous potential and the pharmaceutical industry’s enthusiasm for their incorporation into drug trials, the majority of digital clinical measures continue to require development – primarily, context-specific clinical validation.

Read More

Employee Spotlight: Dudley Tabakin

Posted by VivoSense Team on September 23, 2021

Our Employee Spotlight series highlights a different team member each month, offering a behind-the-scenes look into the people who are an integral part of our success. This month we are talking to Dudley Tabakin, CEO and co-founder.

Read More

Measuring Physical Function and Mobility in Real World Settings

Posted by Jen Blankenship on September 16, 2021

Physical function and mobility are relevant to virtually all clinical indications and are significant determinants of an individual’s quality of life. Because of this, function and mobility are often assessed in clinical trials using subjective questionnaires or in clinic performance tests, but these assessments may not reflect a patient’s lived experience. Wearable sensors provide an opportunity to move assessments of function out into the real world to measure how patients feel and function in their own environments.

Read More

Consumer-Grade Activity Trackers Place in Clinical Research

Posted by Patrick Hankey on September 2, 2021

Wearable sensor devices are an essential element for data collection. As their use is rapidly growing, so is the debate whether consumer or medical-grade wearable sensors are fit for purpose in clinical trials.

Read More

Employee Spotlight: Lindsey Ungerman

Posted by VivoSense Team on August 17, 2021

Our Employee Spotlight series highlights a different team member each month, offering a behind-the-scenes look into the people who are an integral part of our success. This month we are talking to Project Manager, Lindsey Ungerman.

Read More

Employee Spotlight: Jen Blankenship, PhD.

Posted by VivoSense Team on July 20, 2021

Our Employee Spotlight series highlights a different team member each month, offering a behind-the-scenes look into the people who are an integral part of our success. This month we are talking to one of our newest employees Clinical Scientist, Jen Blankenship, PhD.

Read More

Monitoring the Health of First Responders with Wearable Sensors

Posted by Patrick Hankey on July 12, 2021

Recently I had a Q&A session with Alex (Sandy) MacQuarrie, Ph.D., to gain insight into his work with the Hexoskin™ Smart Garment and how it’s used in his research. Hexoskin™ and Astroskin are garment-based platforms that combine ECG, respiratory, pulse oximetry, temperature, and accelerometry sensors.

Read More

How Digital Data Impacts the Development of New Treatments

Posted by Patrick Hankey on June 24, 2021

Digitally connected devices are transforming the way we treat and manage health conditions. They also introduce and improve participant access, engagement, and outcome measurements in clinical trials. Here’s a look at how digital data is paving the way for advances in treatments and recovery.

Read More

Overcoming the Barriers to Adopting Digital Clinical Measures

Posted by Patrick Hankey on May 27, 2021

Advances in AI, digital technology, and wearable devices have played a vital role in accommodating the social distancing restrictions during the COVID-19 pandemic. Emerging digital clinical measures enable clinicians and researchers to maintain continued support for patients and healthcare systems. However, organizational barriers often slow the advancement of the adoption of digital clinical measures. Here are some ways experts can help you overcome the obstacles.

Read More

Subscribe to Email Updates

Stay Connected

Popular